Can Low Dose Naltrexone (LDN) stop additional auto-immune conditions?
Lauren Mathewson, ND – LDN Case Studies – 2022 Conference (LDN; low dose naltrexone)
Lauren Mathewson, ND – LDN Case Studies – 2022 Conference (LDN; low dose naltrexone)
Low-Dose Naltrexone in Rheumatological Diseases (Abstract)
Low-Dose Naltrexone in Rheumatological Diseases Mediterr J Rheumatol 31 March 2023 https://pubmed.ncbi.nlm.nih.gov/37223594/ Background: Naltrexone has been approved for alcohol and opioid abuse by the FDA. At low-dose naltrexone (LDN) has been used in several diseases including chronic pain and autoimmune conditions, including rheumatic disorders. Aim: To review the use of LDN in rheumatic diseases: systemic […]
The LDN Book 3 (LDN; low dose naltrexone)
The LDN 3: To Purchase with discounts before 1st September 2022 Go to ldnresearchtrust.org/ldn-book-3 for full details
Dosing of Low Dose Naltrexone (LDN)
Sleep Issues and Low Dose Naltrexone (LDN)
The Immune System and Low Dose Naltrexone (LDN)
Dr Mathewson – LDN Webinar Presentation 18 May 2022 (LDN; low dose naltrexone)
LDN Webinar Presentation 18 May 2022: Dr Mathewson – LDN as supportive care for Oncology and Autoimmune patients: Case Reviews Sponsored by Innovative Compounding Pharmacy https://icpfolsom.com/
LDN Webinar 18 May 2022 (LDN; low dose naltrexone)
LDN Webinar 18 May 2022 (LDN; low dose naltrexone) LDN Questions Answered Live by Pharmacist Dr Masoud Rashidi – LDN Specialist Dr Sato-Re Dr Mathewson Sponsored by Innovative Compounding Pharmacy icpfolsom.com